179 related articles for article (PubMed ID: 35845006)
21. NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.
Yao Y; Wang Y; Chen F; Huang Y; Zhu S; Leng Q; Wang H; Shi Y; Qian Y
Cell Res; 2012 May; 22(5):836-47. PubMed ID: 22491475
[TBL] [Abstract][Full Text] [Related]
22. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.
Neerincx A; Jakobshagen K; Utermöhlen O; Büning H; Steimle V; Kufer TA
J Immunol; 2014 Sep; 193(6):3090-100. PubMed ID: 25127861
[TBL] [Abstract][Full Text] [Related]
23. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
Neerincx A; Rodriguez GM; Steimle V; Kufer TA
J Immunol; 2012 May; 188(10):4940-50. PubMed ID: 22490867
[TBL] [Abstract][Full Text] [Related]
24. Regulation of class I major histocompatibility complex (MHC) by nucleotide-binding domain, leucine-rich repeat-containing (NLR) proteins.
Robbins GR; Truax AD; Davis BK; Zhang L; Brickey WJ; Ting JP
J Biol Chem; 2012 Jul; 287(29):24294-303. PubMed ID: 22645137
[TBL] [Abstract][Full Text] [Related]
25. Expression regulation and function of NLRC5.
Yao Y; Qian Y
Protein Cell; 2013 Mar; 4(3):168-75. PubMed ID: 23483478
[TBL] [Abstract][Full Text] [Related]
26. NLRC5 overexpression in ovarian tumors remodels the tumor microenvironment and increases T-cell reactivity toward autologous tumor-associated antigens.
Rodriguez GM; Yakubovich E; Murshed H; Maranda V; Galpin KJC; Cudmore A; Hanna AMR; Macdonald E; Ramesh S; Garson K; Vanderhyden BC
Front Immunol; 2023; 14():1295208. PubMed ID: 38235131
[TBL] [Abstract][Full Text] [Related]
27. NLRC5 expression in tumors and its role as a negative prognostic indicator in stage III non-small-cell lung cancer patients.
Li X; Guo F; Liu Y; Chen HJ; Wen F; Zou B; Li D; Qin Q; Liu X; Shen Y; Wang Y
Oncol Lett; 2015 Sep; 10(3):1533-1540. PubMed ID: 26622704
[TBL] [Abstract][Full Text] [Related]
28. NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.
Meissner TB; Liu YJ; Lee KH; Li A; Biswas A; van Eggermond MC; van den Elsen PJ; Kobayashi KS
J Immunol; 2012 May; 188(10):4951-8. PubMed ID: 22490869
[TBL] [Abstract][Full Text] [Related]
29. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
[TBL] [Abstract][Full Text] [Related]
30. NLRC5/CITA: A Key Player in Cancer Immune Surveillance.
Yoshihama S; Vijayan S; Sidiq T; Kobayashi KS
Trends Cancer; 2017 Jan; 3(1):28-38. PubMed ID: 28718425
[TBL] [Abstract][Full Text] [Related]
31. Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I-deficient breast cancer cells.
Zhao MZ; Sun Y; Jiang XF; Liu L; Liu L; Sun LX
Immunol Res; 2019 Dec; 67(6):497-504. PubMed ID: 31900803
[TBL] [Abstract][Full Text] [Related]
32. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis.
Yoo JS; Sasaki M; Cho SX; Kasuga Y; Zhu B; Ouda R; Orba Y; de Figueiredo P; Sawa H; Kobayashi KS
Nat Commun; 2021 Nov; 12(1):6602. PubMed ID: 34782627
[TBL] [Abstract][Full Text] [Related]
33. MHC class I transactivator NLRC5 in host immunity, cancer and beyond.
Cho SX; Vijayan S; Yoo JS; Watanabe T; Ouda R; An N; Kobayashi KS
Immunology; 2021 Mar; 162(3):252-261. PubMed ID: 32633419
[TBL] [Abstract][Full Text] [Related]
34. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
[TBL] [Abstract][Full Text] [Related]
35. NLRC5 potentiates anti-tumor CD8
Zhang J; Guo B; Chen JH; Liu XJ; Zhang JH; Zhu HQ; Wang WY; Tang ZH; Wei B; Cao YX; Zhan L
Transl Oncol; 2023 Oct; 36():101742. PubMed ID: 37531863
[TBL] [Abstract][Full Text] [Related]
36. NLRC5, a promising new entry in tumor immunology.
Chelbi ST; Guarda G
J Immunother Cancer; 2016; 4():39. PubMed ID: 27437103
[TBL] [Abstract][Full Text] [Related]
37. The Obligate Intracellular Bacterium
Rodino KG; Adcox HE; Martin RK; Patel V; Conrad DH; Carlyon JA
Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30559222
[No Abstract] [Full Text] [Related]
38. MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.
Cornel AM; Mimpen IL; Nierkens S
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630675
[TBL] [Abstract][Full Text] [Related]
39. Role of zebrafish NLRC5 in antiviral response and transcriptional regulation of MHC related genes.
Wu XM; Hu YW; Xue NN; Ren SS; Chen SN; Nie P; Chang MX
Dev Comp Immunol; 2017 Mar; 68():58-68. PubMed ID: 27876605
[TBL] [Abstract][Full Text] [Related]
40. NLRC5: a key regulator of MHC class I-dependent immune responses.
Kobayashi KS; van den Elsen PJ
Nat Rev Immunol; 2012 Dec; 12(12):813-20. PubMed ID: 23175229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
